EUVIMEDEUVIMED entdecken
Crossref

Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding

Douglas Faries iD, Chenyin Gao, Xiang Zhang, Chad Hazlett, James Stamey, Shu Yang iD, Peng Ding, Mingyang Shan iD, Kristin Sheffield, Nancy Dreyer iD

Pharmaceutical Statistics · 2025

DOI: 10.1002/pst.2457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Douglas Faries und 9 weiteren Autor:innen. Beteiligte Einrichtung: Real-World Access and Analytics, Eli Lilly & Company, Indianapolis, USA. Hauptthemen laut MEDLINE: Observational Studies as Topic, Research Design. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The assumption of “no unmeasured confounders” is a critical but unverifiable assumption required for causal inference yet quantitative sensitivity analyses to assess robustness of real‐world evidence remains under‐utilized. The lack of use is likely in part due to complexity of implementation and often specific and restrictive data requirements for application of each method. With the advent of methods that are broadly applicable in that they do not require identification of a specific unmeasured confounder—along with publicly available code for implementation—roadblocks toward broader use of sensitivity analyses are decreasing. To spur greater application, here we offer a good practice guidance to address the potential for unmeasured confounding at both the design and analysis stages, including framing questions and an analytic toolbox for researchers. The questions at the design stage guide the researcher through steps evaluating the potential robustness of the design while encouraging gathering of additional data to reduce uncertainty due to potential confounding. At the analysis stage, the questions guide quantifying the robustness of the observed result and providing researchers with a clearer indication of the strength of their conclusions. We demonstrate the application of this guidance using simulated data based on an observational fibromyalgia study, applying multiple methods from our analytic toolbox for illustration purposes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Observational Studies as TopicResearch DesignHumansBiasConfounding Factors, EpidemiologicData Interpretation, StatisticalComputer Simulation

Stichwörter der Autor:innen

biascausal inferenceconfoundingreal‐world evidencesensitivity

Autor:innen und Institutionen

  • Real-World Access and Analytics, Eli Lilly & Company, Indianapolis, USA.
  • Department of Statistics, North Carolina State University, Raleigh, North Carolina, USA.
  • Medical Affairs Biostatistics, CSL Behring, King of Prussia, USA.
  • Departments of Statistics & Data Science and Political Science, University of California at Los Angeles, Los Angeles, USA.
  • Department of Statistical Science, Baylor University, Waco, USA.
  • Department of Statistics, University of California Berkeley, Berkeley, USA.

ORCID-Profile: Douglas Faries, Shu Yang, Mingyang Shan, Nancy Dreyer

Förderung

  • Eli Lilly and Company

Zitieren

APA

Faries, D., Gao, C., Zhang, X., Hazlett, C., Stamey, J., Yang, S., Ding, P., Shan, M., Sheffield, K., & Dreyer, N. (2025). Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2457

Vancouver

Faries D, Gao C, Zhang X, Hazlett C, Stamey J, Yang S, et al. Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding. Pharmaceutical Statistics. 2025. doi:10.1002/pst.2457

BibTeX
@article{Faries2025,
  author = {Faries, Douglas and Gao, Chenyin and Zhang, Xiang and Hazlett, Chad and Stamey, James and Yang, Shu and Ding, Peng and Shan, Mingyang and Sheffield, Kristin and Dreyer, Nancy},
  title = {Real Effect or Bias? Good Practices for Evaluating the Robustness of Evidence From Comparative Observational Studies Through Quantitative Sensitivity Analysis for Unmeasured Confounding},
  journal = {Pharmaceutical Statistics},
  year = {2025},
  doi = {10.1002/pst.2457}
}
Kostenlos starten →